Sleep quality following initiation of NIV in chronic hyperkapnic COPD

• Conditions: J44.9; J96.1; Chronic obstructive pulmonary disease, unspecified; Chronic respiratory failure

• Registration Number: DRKS00015496
• Lead Sponsor: Asklepios Fachkliniken München-Gauting Abteilung für Intensiv-, Schlaf- und Beatmungsmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-09-10
• Study Completion: 2020-04-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Indication for home NIV in COPD following national guidelines

Exclusion Criteria

recent acute respiratory failure with hospital admission in the last 4 weeks, NIV-users

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rapid-Eye-Movement (REM)-sleep assessed by polysomnography at baseline and following 3 months of home NIV.

Secondary Outcome Measures

Name	Time	Method
Accordingly to primary endpoint results of polysomnography, lung function, gas exchange and quality of life will be assessed at baseline and following 3 months of home NIV.